These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19135989)

  • 1. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
    Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
    Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease.
    Schlitt A; Bickel C; Thumma P; Blankenberg S; Rupprecht HJ; Meyer J; Jiang XC
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1857-62. PubMed ID: 12947020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
    Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
    Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
    Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endothelial cholesterol efflux is promoted by the high-density lipoprotein anionic peptide factor.
    Domingo N; Mastellone I; Grès S; Marin V; Lorec AM; Tosini F; Grosclaude J; Farnarier C; Chanussot F
    Metabolism; 2005 Aug; 54(8):1087-94. PubMed ID: 16092060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High density lipoprotein-anionic peptide factor effect on reverse cholesterol transport in type 2 diabetic patients with and without coronary artery disease.
    Attia N; Lorec AM; Domingo N; Nakbi A; Hammami S; Ben Hamda K; Châaba R; Masmoudi AS; Moulin P; Portugal H; Lairon D; Chanussot F; Hammami M
    Clin Biochem; 2010 Sep; 43(13-14):1079-84. PubMed ID: 20599873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
    Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
    Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid transfer protein in hemodialysis patients.
    Schlitt A; Heine GH; Jiang XC; Messow M; Blankenberg S; Rupprecht HJ; Ulrich C; Buerke M; Werdan K; Lackner KJ; Köhler H; Girndt M
    Am J Nephrol; 2007; 27(2):138-43. PubMed ID: 17308375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of human plasma phospholipid transfer protein mass and activity.
    Jauhiainen M; Ehnholm C
    Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
    O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
    Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
    Dullaart RPF; Gruppen EG; Dallinga-Thie GM
    Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
    Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
    Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.
    Ooi EM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PH
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):752-9. PubMed ID: 17121526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
    Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
    Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfacial and lipid transfer properties of human phospholipid transfer protein: implications for the transfer mechanism of phospholipids.
    Setälä NL; Holopainen JM; Metso J; Wiedmer SK; Yohannes G; Kinnunen PK; Ehnholm C; Jauhiainen M
    Biochemistry; 2007 Feb; 46(5):1312-9. PubMed ID: 17260960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
    Hsieh MC; Tien KJ; Chang SJ; Lo CS; Hsin SC; Hsiao JY; Hsu SC; Liang HT; Chen HC; Shin SJ; Lin SR
    Metabolism; 2007 Jun; 56(6):745-50. PubMed ID: 17512305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.